The intersection of technology and human capability, once confined to the realm of science fiction, is becoming increasingly tangible. The startup Phantom Neuro has secured $19 million in funding to advance its innovative approach of linking human nerve signals to prosthetic limbs via an implanted device that resembles a wristband.
Phantom Neuro has achieved significant regulatory milestones, gaining two FDA designations: a Breakthrough Device and a TAP designation, which facilitate a streamlined path toward commercialisation. Their technology taps into the sensations experienced by amputees who still perceive their missing limbs, a phenomenon known as the phantom limb sensation. Utilizing their proprietary “Phantom X” software, the company claims to have achieved 94% accuracy in translating nerve impulses into movements of prosthetics, with even higher accuracy anticipated upon implantation beneath the skin.
Led by Ottobock, a German manufacturer of prosthetics, the investment round included previous backers such as Breakout Ventures and new investors like Actual VC and METIS Innovative, contributing to a total funding of $28 million so far.
Phantom Neuro was founded by Dr. Connor Glass, who has transitioned from a military aspiration to the field of neuroscience. Initially enrolled in ROTC, Glass shifted gears after confronting physical limitations due to recurrent stress fractures. Inspired by an early exposure to brain surgery, he pursued a pre-medical path and later graduated from medical school. His time at Johns Hopkins University highlighted the cumbersome and invasive nature of existing brain implant technologies, spurring his interest in developing a more scalable solution.
Recognising the potential of the body’s neuro-network and the detailed signals emitted by nerve endings, Phantom Neuro positions itself at the forefront of improving control over prosthetics. Their innovative device is seen as a progression alongside established implant procedures used in various medical applications.
The company’s first phase focuses on prosthetic arms, with intentions to expand to leg prosthetics in the future. Additionally, this technology holds promise beyond aiding amputees, with potential applications in remote control of robots and enhancing AI systems to mimic human movement.
Dr. Glass’s vision includes collaborating with established prosthetic manufacturers to ensure a seamless integration of their nerve-prosthetic interface technology into future products. As noted by Dr. Arne Kreitz, CFO of Ottobock, the strategy of developing an interface that blends with human physiology while maintaining low invasiveness is crucial to both research and development.
In summary, Phantom Neuro is paving the way toward a future where technology and human capabilities converge more cohesively, transforming the lives of those reliant on prosthetics and possibly influencing broader technological advancements.
Fanpage: TechArena.au
Watch more about AI – Artificial Intelligence
